JOSEPH KWENTUS: Open Payments
NPI 1477582096 · FLOWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$218 in 6 payments from 5 companies in 2025. Trend: 2023 $898 · 2024 $2,062 · 2025 $218
Food & beverage: $218
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 1 | $124 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Lundbeck LLC | 1 | $26 |
| ABBVIE INC. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: KISUNLA, CAPLYTA, REXULTI, VRAYLAR, UZEDY.
Industry payments across MS — which companies pay providers there.
